In the latest session, Gritstone Bio Inc (NASDAQ: GRTS) closed at $2.57 down -8.21% from its previous closing price of $2.80. In other words, the price has decreased by -$0.2300 from its previous closing price. On the day, 2251298 shares were traded.
Ratios:
For a deeper understanding of Gritstone Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 3.20. In the meantime, Its Debt-to-Equity ratio is 2.02 whereas as Long-Term Debt/Eq ratio is at 1.89.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on February 28, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $4.
On March 28, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $8.B. Riley Securities initiated its Buy rating on March 28, 2023, with a $8 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 23 ’23 when Economides Vassiliki bought 12,000 shares for $1.90 per share. The transaction valued at 22,829 led to the insider holds 214,058 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTS now has a Market Capitalization of 252.03M and an Enterprise Value of 277.53M. For the stock, the TTM Price-to-Sale (P/S) ratio is 189.50 while its Price-to-Book (P/B) ratio in mrq is 4.84. Its current Enterprise Value per Revenue stands at 208.51 whereas that against EBITDA is -2.19.
Stock Price History:
The Beta on a monthly basis for GRTS is 0.40, which has changed by -6.88% over the last 52 weeks, in comparison to a change of 27.39% over the same period for the S&P500. Over the past 52 weeks, GRTS has reached a high of $3.33, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 2.4532, while the 200-Day Moving Average is calculated to be 2.0237.
Shares Statistics:
For the past three months, GRTS has traded an average of 2.00M shares per day and 1.45M over the past ten days. A total of 97.59M shares are outstanding, with a floating share count of 89.41M. Insiders hold about 8.82% of the company’s shares, while institutions hold 38.49% stake in the company. Shares short for GRTS as of Mar 15, 2024 were 8.82M with a Short Ratio of 4.42, compared to 9.14M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.99% and a Short% of Float of 10.14%.
Earnings Estimates
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.33 for the current quarter, with a high estimate of -$0.26 and a low estimate of -$0.39, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.21 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$0.62 and -$1.47 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.96, with 5 analysts recommending between -$0.6 and -$1.48.
